WannaCry ransomware attack
- Creating a Secure Organisation
- Resolving Critical Issues and Crises
WannaCry ransomware attack - what next?
On 12 May, the WannaCry ransomware attack began, impacting companies worldwide. The campaign was indiscriminate and overran companies in multiple sectors across the world. It may prove to be one of the largest cyber-attacks in history. And it won’t be the last.
In this webinar, our cyber experts provide concrete detail on how the attacks were mounted and their effect. They draw from Control Risks’ own Cyber Threat Intelligence and from their experience of helping clients deal with both this attack and similar attacks in the past.
- What happened and why
- How the campaign is likely to evolve
- What will the next attack look like?
- How to prevent a breach
- Actions in the event of a breach
- Toby Chinn, Head of Cyber Security
- Nicolas Reys, Head of Cyber Threat Intelligence
Fill in your details below to access a recording of the webinar.
We are pleased to release our forth quarter report on political violence and violent organised crime incidents around the world. This report draws upon and highlights the extensive incident mapping data and analysis that is available within CORE, the essential risk monitoring toolkit from Control Risks.
The Global Insight
Join Charles Hecker and Control Risks experts Jonathan Wood and Shawn VanSlyke for a discussion about the implications of the 6 January storming of the US Capitol for the US security environment.
As we move into 2021, legal and compliance teams – like the companies they work for – undoubtedly face challenges. Find out more about the five key issues for the upcoming year.
Our RiskMap coverage shows that dealmakers need to have a range of issues in mind as they consider transactions in 2021. Find out more about the three key considerations here.
The Global Insight
Join Charles Hecker and Control Risks experts Caroline Naumann and Joseph Smith for a conversation about the unique challenges facing the global rollout of COVID-19 vaccines.